HomeExit StrategyHough Ear Institute Licenses Hearing Loss Treatment

Hough Ear Institute Licenses Hearing Loss Treatment

Hough Ear Institute licensed a novel hearing-loss treatment, which a local team of Hough scientists developed, to Boehringer Ingelheim, an international pharmaceutical firm.

The drug was codeveloped by OKC-based Autigen, a subsidiary of Otologic. Dr. Elaine Hamm is president of both.

“Our drug works to combat hearing loss caused by a loss of cells in the cochlea called ‘inner hair cells.’” Hamm said. “Previously, once you lost those, they wouldn’t grow back. Our drug causes them to grow back.”

Boehringer Ingelheim intends to take the drug through the testing process with the aim of bringing it to market. In preclinical models, the scientific team led by Drs. Xiaoping Du, Matthew West and Richard Kopke has regenerated these sensory hair cells.

Sign up for our weekly newsletter for our weekly newsletter and get the latest 405 news & events happening straight to your inbox!

Featured Stories

The Wave and the Wheat

Rachel Cannon and Matt Payne took the Oklahoma Film industry by storm when they created Prairie Surf Media a mere two years ago. Now,...

The Business of Basketball

Only 27 out of the roughly 19,500 cities in America can claim an NBA team.  .14% And Oklahoma City lays claim to the Thunder. In October, the...

All that Glitters

This fall, University of Oklahoma President Joe Harroz welcomed the largest freshman class in the school’s 132-year history, more than a quarter who are...